Back to BAKER BROS. ADVISORS LP BAKER BROS. ADVISORS LP

KNSAKNSA
Showing 8 of 9 quarters

Position history for BAKER BROS. ADVISORS LPBAKER BROS. ADVISORS LP's holdings in KINIKSA PHARMACEUTICALS INTE

Yes. Baker Bros. Advisors holds 2,834,643 shares of KNSA (Kiniksa Pharmaceuticals Inte), worth $181.3M, as of its Q2 2026 13F filing. It increased the position by 8,397 shares (+0.3%) from Q1 2026. Baker Bros. Advisors has held KNSA in every 13F on record since Q2 2024, 9 quarterly filings. KNSA is 0.9% of Baker Bros. Advisors' reported 13F portfolio.

Current Value

$181.3M

Current Shares

2.8M

Total Value Change

+$110.8M

Total Shares Change

+16,320

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.8M
+0.3%
$181.3M0.9%$63.95
43
2026-Q1
Unchanged
2.8M
0.0%
$136.1M0.8%$48.15
0
2025-Q4
Increased
2.8M
+0.1%
$116.6M0.7%$41.25
42
2025-Q3
Unchanged
2.8M
0.0%
$109.7M0.8%$38.83
0
2025-Q2
Increased
2.8M
+0.2%
$78.2M0.8%$27.67
42
2025-Q1
Unchanged
2.8M
0.0%
$62.6M0.7%$22.21
0
2024-Q4
Unchanged
2.8M
0.0%
$55.7M0.6%$19.78
0
2024-Q3
Unchanged
2.8M
0.0%
$70.4M0.7%$24.99
0

Other major holders of KNSA: FMR LLC, BlackRock, Inc., VANGUARD GROUP INC, VANGUARD PORTFOLIO MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used